Global Patient In-vivo Dosimetry (IVD) System Market Size, Share, Trends and Forecast 2021-2027

Description

The global Patient In-vivo Dosimetry (IVD) System market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Patient In-vivo Dosimetry (IVD) System Scope and Segment
Patient In-vivo Dosimetry (IVD) System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Patient In-vivo Dosimetry (IVD) System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
Landauer
Chiyoda Technol Corporation
Mirion Technologies
Thermo Fisher Scientific
Fuji Electric
Hitachi Aloka
Bertin Instruments
Tracerco
ATOMTEX
Panasonic
Polimaster
Renri
RadPro International GmbH
Ludlum Measurements
XZ LAB
Patient In-vivo Dosimetry (IVD) System Breakdown Data by Type
Portable
Fixed
Patient In-vivo Dosimetry (IVD) System Breakdown Data by Application
Medical
Scientific Research
Others
Regional and Country-level Analysis
The Patient In-vivo Dosimetry (IVD) System market is analysed and market size information is provided by regions (countries).
The key regions covered in the Patient In-vivo Dosimetry (IVD) System market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.

TABLE OF CONTENT

Table of Contents


1 Study Coverage
1.1 Patient In-vivo Dosimetry (IVD) System Product Introduction
1.2 Market by Type
1.2.1 Global Patient In-vivo Dosimetry (IVD) System Market Size Growth Rate by Type
1.2.2 Portable
1.2.3 Fixed
1.3 Market by Application
1.3.1 Global Patient In-vivo Dosimetry (IVD) System Market Size Growth Rate by Application
1.3.2 Medical
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Patient In-vivo Dosimetry (IVD) System Sales Estimates and Forecasts 2016-2027
2.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Estimates and Forecasts 2016-2027
2.3 Global Patient In-vivo Dosimetry (IVD) System Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Patient In-vivo Dosimetry (IVD) System Regions by Sales
2.4.1 Global Top Patient In-vivo Dosimetry (IVD) System Regions by Sales (2016-2021)
2.4.2 Global Top Patient In-vivo Dosimetry (IVD) System Regions by Sales (2022-2027)
2.5 Global Top Patient In-vivo Dosimetry (IVD) System Regions by Revenue
2.5.1 Global Top Patient In-vivo Dosimetry (IVD) System Regions by Revenue (2016-2021)
2.5.2 Global Top Patient In-vivo Dosimetry (IVD) System Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Patient In-vivo Dosimetry (IVD) System Sales by Manufacturers
3.1.1 Global Top Patient In-vivo Dosimetry (IVD) System Manufacturers by Sales (2016-2021)
3.1.2 Global Top Patient In-vivo Dosimetry (IVD) System Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Patient In-vivo Dosimetry (IVD) System Sales in 2020
3.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Manufacturers
3.2.1 Global Top Patient In-vivo Dosimetry (IVD) System Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Patient In-vivo Dosimetry (IVD) System Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Patient In-vivo Dosimetry (IVD) System Revenue in 2020
3.3 Global Patient In-vivo Dosimetry (IVD) System Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Patient In-vivo Dosimetry (IVD) System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Patient In-vivo Dosimetry (IVD) System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Patient In-vivo Dosimetry (IVD) System Sales by Type
4.1.1 Global Patient In-vivo Dosimetry (IVD) System Historical Sales by Type (2016-2021)
4.1.2 Global Patient In-vivo Dosimetry (IVD) System Forecasted Sales by Type (2022-2027)
4.1.3 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2027)
4.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Type
4.2.1 Global Patient In-vivo Dosimetry (IVD) System Historical Revenue by Type (2016-2021)
4.2.2 Global Patient In-vivo Dosimetry (IVD) System Forecasted Revenue by Type (2022-2027)
4.2.3 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2016-2027)
4.3 Global Patient In-vivo Dosimetry (IVD) System Price by Type
4.3.1 Global Patient In-vivo Dosimetry (IVD) System Price by Type (2016-2021)
4.3.2 Global Patient In-vivo Dosimetry (IVD) System Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Patient In-vivo Dosimetry (IVD) System Sales by Application
5.1.1 Global Patient In-vivo Dosimetry (IVD) System Historical Sales by Application (2016-2021)
5.1.2 Global Patient In-vivo Dosimetry (IVD) System Forecasted Sales by Application (2022-2027)
5.1.3 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2027)
5.2 Global Patient In-vivo Dosimetry (IVD) System Revenue by Application
5.2.1 Global Patient In-vivo Dosimetry (IVD) System Historical Revenue by Application (2016-2021)
5.2.2 Global Patient In-vivo Dosimetry (IVD) System Forecasted Revenue by Application (2022-2027)
5.2.3 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2016-2027)
5.3 Global Patient In-vivo Dosimetry (IVD) System Price by Application
5.3.1 Global Patient In-vivo Dosimetry (IVD) System Price by Application (2016-2021)
5.3.2 Global Patient In-vivo Dosimetry (IVD) System Price Forecast by Application (2022-2027)

6 North America
6.1 North America Patient In-vivo Dosimetry (IVD) System Market Size by Type
6.1.1 North America Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2027)
6.1.2 North America Patient In-vivo Dosimetry (IVD) System Revenue by Type (2016-2027)
6.2 North America Patient In-vivo Dosimetry (IVD) System Market Size by Application
6.2.1 North America Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2027)
6.2.2 North America Patient In-vivo Dosimetry (IVD) System Revenue by Application (2016-2027)
6.3 North America Patient In-vivo Dosimetry (IVD) System Market Size by Country
6.3.1 North America Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2027)
6.3.2 North America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Patient In-vivo Dosimetry (IVD) System Market Size by Type
7.1.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2027)
7.1.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Type (2016-2027)
7.2 Europe Patient In-vivo Dosimetry (IVD) System Market Size by Application
7.2.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2027)
7.2.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Application (2016-2027)
7.3 Europe Patient In-vivo Dosimetry (IVD) System Market Size by Country
7.3.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2027)
7.3.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Patient In-vivo Dosimetry (IVD) System Market Size by Type
8.1.1 Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2027)
8.1.2 Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Type (2016-2027)
8.2 Asia Pacific Patient In-vivo Dosimetry (IVD) System Market Size by Application
8.2.1 Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2027)
8.2.2 Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Application (2016-2027)
8.3 Asia Pacific Patient In-vivo Dosimetry (IVD) System Market Size by Region
8.3.1 Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region (2016-2027)
8.3.2 Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Patient In-vivo Dosimetry (IVD) System Market Size by Type
9.1.1 Latin America Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2027)
9.1.2 Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Type (2016-2027)
9.2 Latin America Patient In-vivo Dosimetry (IVD) System Market Size by Application
9.2.1 Latin America Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2027)
9.2.2 Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Application (2016-2027)
9.3 Latin America Patient In-vivo Dosimetry (IVD) System Market Size by Country
9.3.1 Latin America Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2027)
9.3.2 Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Market Size by Type
10.1.1 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Type (2016-2027)
10.1.2 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Type (2016-2027)
10.2 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Market Size by Application
10.2.1 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Application (2016-2027)
10.2.2 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Application (2016-2027)
10.3 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Market Size by Country
10.3.1 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Country (2016-2027)
10.3.2 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Landauer
11.1.1 Landauer Corporation Information
11.1.2 Landauer Overview
11.1.3 Landauer Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Landauer Patient In-vivo Dosimetry (IVD) System Product Description
11.1.5 Landauer Recent Developments
11.2 Chiyoda Technol Corporation
11.2.1 Chiyoda Technol Corporation Corporation Information
11.2.2 Chiyoda Technol Corporation Overview
11.2.3 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Description
11.2.5 Chiyoda Technol Corporation Recent Developments
11.3 Mirion Technologies
11.3.1 Mirion Technologies Corporation Information
11.3.2 Mirion Technologies Overview
11.3.3 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Description
11.3.5 Mirion Technologies Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Overview
11.4.3 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Description
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Fuji Electric
11.5.1 Fuji Electric Corporation Information
11.5.2 Fuji Electric Overview
11.5.3 Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Description
11.5.5 Fuji Electric Recent Developments
11.6 Hitachi Aloka
11.6.1 Hitachi Aloka Corporation Information
11.6.2 Hitachi Aloka Overview
11.6.3 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Description
11.6.5 Hitachi Aloka Recent Developments
11.7 Bertin Instruments
11.7.1 Bertin Instruments Corporation Information
11.7.2 Bertin Instruments Overview
11.7.3 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Description
11.7.5 Bertin Instruments Recent Developments
11.8 Tracerco
11.8.1 Tracerco Corporation Information
11.8.2 Tracerco Overview
11.8.3 Tracerco Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Tracerco Patient In-vivo Dosimetry (IVD) System Product Description
11.8.5 Tracerco Recent Developments
11.9 ATOMTEX
11.9.1 ATOMTEX Corporation Information
11.9.2 ATOMTEX Overview
11.9.3 ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Description
11.9.5 ATOMTEX Recent Developments
11.10 Panasonic
11.10.1 Panasonic Corporation Information
11.10.2 Panasonic Overview
11.10.3 Panasonic Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Panasonic Patient In-vivo Dosimetry (IVD) System Product Description
11.10.5 Panasonic Recent Developments
11.11 Polimaster
11.11.1 Polimaster Corporation Information
11.11.2 Polimaster Overview
11.11.3 Polimaster Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Polimaster Patient In-vivo Dosimetry (IVD) System Product Description
11.11.5 Polimaster Recent Developments
11.12 Renri
11.12.1 Renri Corporation Information
11.12.2 Renri Overview
11.12.3 Renri Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Renri Patient In-vivo Dosimetry (IVD) System Product Description
11.12.5 Renri Recent Developments
11.13 RadPro International GmbH
11.13.1 RadPro International GmbH Corporation Information
11.13.2 RadPro International GmbH Overview
11.13.3 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Description
11.13.5 RadPro International GmbH Recent Developments
11.14 Ludlum Measurements
11.14.1 Ludlum Measurements Corporation Information
11.14.2 Ludlum Measurements Overview
11.14.3 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Description
11.14.5 Ludlum Measurements Recent Developments
11.15 XZ LAB
11.15.1 XZ LAB Corporation Information
11.15.2 XZ LAB Overview
11.15.3 XZ LAB Patient In-vivo Dosimetry (IVD) System Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 XZ LAB Patient In-vivo Dosimetry (IVD) System Product Description
11.15.5 XZ LAB Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Patient In-vivo Dosimetry (IVD) System Value Chain Analysis
12.2 Patient In-vivo Dosimetry (IVD) System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Patient In-vivo Dosimetry (IVD) System Production Mode & Process
12.4 Patient In-vivo Dosimetry (IVD) System Sales and Marketing
12.4.1 Patient In-vivo Dosimetry (IVD) System Sales Channels
12.4.2 Patient In-vivo Dosimetry (IVD) System Distributors
12.5 Patient In-vivo Dosimetry (IVD) System Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Patient In-vivo Dosimetry (IVD) System Industry Trends
13.2 Patient In-vivo Dosimetry (IVD) System Market Drivers
13.3 Patient In-vivo Dosimetry (IVD) System Market Challenges
13.4 Patient In-vivo Dosimetry (IVD) System Market Restraints

14 Key Findings in The Global Patient In-vivo Dosimetry (IVD) System Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample